← Leaderboards
Oscar Juarez
Illinois Institute Of Technology
$2,483,552
Attributed
$2,483,552
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $557.1K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,483,552 · 2
By mechanism
R01$2,055,320 · 1
R15$428,232 · 1
Top collaborators
No co-investigators on record.
Most similar at Illinois Institute Of Technology
Same institution · by research overlap
- Nathan Baird$30,694
Others in their field
Other Emerging Leaders on “Pathogenic Bacteria”
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Urs Ochsner · Crestone, Inc.$16,946,670
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
- Jay Evans · University Of Montana$12,765,004
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$12,637,001
- Thomas Dick · Rbhs-New Jersey Medical School$11,136,932
Research focus
Pathogenic BacteriaProteinsIonsPathogenPhenothiazinesPropertyDrug EffluxFamilyMutantOxidation-ReductionPharmaceutical PreparationsBindingBinding SitesPlayAnalogDockingDrug TargetingEnzymesComplexMembraneNa(+)-K(+)-Exchanging AtpaseNutrientAntibioticsRegulation
Grant awards (5)
DEVELOPMENT OF A NOVEL CLASS OF ANTIBIOTICS AGAINST VIBRIO CHOLERAE NA+-NQR$472,080
R01 · FY2025 · AI · contact PI
DEVELOPMENT OF A NOVEL CLASS OF ANTIBIOTICS AGAINST VIBRIO CHOLERAE NA+-NQR$472,080
R01 · FY2024 · AI · contact PI
DEVELOPMENT OF A NOVEL CLASS OF ANTIBIOTICS AGAINST VIBRIO CHOLERAE NA+-NQR$557,080
R01 · FY2023 · AI · contact PI
DEVELOPMENT OF A NOVEL CLASS OF ANTIBIOTICS AGAINST VIBRIO CHOLERAE NA+-NQR$554,080
R01 · FY2022 · AI · contact PI
Role of flavin radicals and one-electron transitions in the ion pumping mechanism of the bacterial respiratory complex Na+-NQR$428,232
R15 · FY2019 · GM · contact PI